Medical Termination of First Trimester Miscarriages
Objective: To study the success rate of medical termination of first trimester non viable pregnancies with misoprostol 1200µg.The secondary end points were to study the prevalence of unwanted side effects.
Study design: Interventional: Quasi experimental study.
Setting: Department of Obstetrics & Gynaecology. Fatima Memorial Hospital Lahore.
Study duration: 18 months (July 05 to January 07).
Sample technique: Non-probable sampling: Purposive.
Sample: Eighty one women seeking medical attention for early miscarriages.
Method: Women with non viable, first trimester miscarriage were selected for termination with misoprostol 1200µg in divided doses over 24 hours.
Main outcome measures: Main outcome measure was the proportion of successful resolution of miscarriage without surgical intervention. Secondary outcomes were incidence of pain, heavy vaginal bleeding (>500ml), infection, pyrexia and gastrointestinal side effects.
Results: Eighty-one women were recruited in the study. Treatment was successful in 43 patients (53.1%) with 38 patients (46.9%) requiring surgical evacuation due to failure of treatment. Major side effect experienced by patient was pain (42.0%) requiring analgesia for relief. Nausea and vomiting was seen in (18.5%). Two patients (2.5%) had diarrhea and three patients (3.7%) had pyrexia. Five patients (6.2%) had heavy vaginal bleeding (>500ml). None had PID.
Conclusion: Medical treatment of first trimester miscarriage is non-invasive and cost effective method of treatment and a safe alternative to D&C. Our study demonstrated the efficiency and safety of administration of 1200μg of misoprostol orally for management of missed, incomplete and an embryonic miscarriage.
Keywords: Misoprostol, medical management, miscarriage.
Copyright (c) 2010 Annals of King Edward Medical University
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.